Genmab and Johnson & Johnson Rake in the Bucks Together, Sparking Takeover Speculation Post author:Sam Post published:November 29, 2017 Post category:BioPharma Genmab just received a $20M milestone payment from Janssen Biotech. Source: BioSpace You Might Also Like Kura Oncology To Report Fourth Quarter And Full Year 2016 Financial Results March 7, 2017 Flushed With Cash, Shanghai Pharma Hunts for M&A in the U.S. and Europe January 23, 2018 Ipsen Announces FDA Approval Of Dysport (Abobotulinumtoxina) For The Treatment Of Lower Limb Spasticity In Adults June 15, 2017
Ipsen Announces FDA Approval Of Dysport (Abobotulinumtoxina) For The Treatment Of Lower Limb Spasticity In Adults June 15, 2017
